STOCK TITAN

[Form 4] Walgreens Boots Alliance, Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Walgreens Boots Alliance director Ginger L. Graham was granted 16,820.86 phantom stock units on 08/13/2025 as non-employee director compensation under the company's 2021 Omnibus Incentive Plan. Each phantom unit is the economic equivalent of one share of common stock and will be settled following termination of service in accordance with the Plan. The reported per-unit value for the grant is $11.89, and the filing shows 112,782.56 phantom stock units beneficially owned following the transaction, which includes units issued in lieu of dividends.

The Form 4 was signed on behalf of Ms. Graham by an attorney-in-fact, Paul Ingram, on 08/15/2025. The filing is a routine disclosure of director compensation and deferred equity-like awards under the issuer’s director pay framework.

La direttrice di Walgreens Boots Alliance, Ginger L. Graham, ha ricevuto 16.820,86 unità azionarie fantasma in data 13/08/2025 come compenso per direttore non dipendente ai sensi del piano 2021 Omnibus Incentive Plan dell’azienda. Ogni unità fantasma corrisponde economicamente a una azione ordinaria e verrà liquidata alla cessazione del servizio in conformità con il Piano. Il valore per unità riportato per la concessione è di $11.89, e la comunicazione indica la detenzione di 112.782,56 unità azionarie fantasma dopo l’operazione, comprensive delle unità emesse in luogo dei dividendi.

Il Modulo 4 è stato firmato per conto della Sig.ra Graham da un procuratore, Paul Ingram, in data 15/08/2025. La comunicazione è una divulgazione di routine relativa al compenso dei direttori e alle assegnazioni differite analoghe all’equity previste dal quadro retributivo per i direttori dell’emittente.

La directora de Walgreens Boots Alliance, Ginger L. Graham, recibió 16.820,86 unidades de acciones fantasma el 13/08/2025 como compensación por su cargo como directora no empleada bajo el Plan Omnibus de Incentivos 2021 de la compañía. Cada unidad fantasma equivale económicamente a una acción ordinaria y se liquidará al terminar el servicio de acuerdo con el Plan. El valor por unidad reportado para la concesión es de $11.89, y la presentación muestra 112.782,56 unidades de acciones fantasma en propiedad tras la transacción, incluyendo las unidades emitidas en lugar de dividendos.

El Formulario 4 fue firmado en nombre de la Sra. Graham por un apoderado, Paul Ingram, el 15/08/2025. La presentación es una divulgación de rutina sobre la compensación de directores y las adjudicaciones diferidas similares a acciones dentro del marco de remuneración para directores del emisor.

Walgreens Boots Alliance 이사인 Ginger L. Graham은 2025년 8월 13일 회사의 2021 Omnibus Incentive Plan에 따라 비임원 이사 보수로 16,820.86개의 팬텀 스톡 단위를 부여받았습니다. 각 팬텀 단위는 보통주 1주와 동일한 경제적 가치를 가지며, 플랜에 따라 서비스 종료 시 정산됩니다. 부여에 대한 단위당 보고 가치는 $11.89이며, 제출서류는 거래 후 배당 대신 발행된 단위를 포함하여 112,782.56개의 팬텀 스톡 단위를 실질적으로 보유하고 있음을 보여줍니다.

Form 4는 2025년 8월 15일 Ms. Graham을 대신하여 대리인 Paul Ingram이 서명했습니다. 해당 제출은 발행인의 이사 보수 체계에 따른 이사 보수 및 유사 주식형 이연 수여에 대한 일상적인 공시입니다.

La directrice de Walgreens Boots Alliance, Ginger L. Graham, s’est vu accorder 16 820,86 unités fantômes d’actions le 13/08/2025 en tant que rémunération de directrice non salariée dans le cadre du Plan d’incitation omnibus 2021 de la société. Chaque unité fantôme équivaut économiquement à une action ordinaire et sera réglée lors de la cessation de fonctions conformément au Plan. La valeur par unité déclarée pour l’attribution est de $11.89, et le dépôt indique la détention bénéficiaire de 112 782,56 unités fantômes d’actions après la transaction, incluant les unités émises en lieu et place des dividendes.

Le formulaire 4 a été signé pour Mme Graham par un mandataire, Paul Ingram, le 15/08/2025. Le dépôt constitue une divulgation de routine concernant la rémunération des administrateurs et les attributions différées assimilées à des actions dans le cadre du régime de rémunération des administrateurs de l’émetteur.

Walgreens Boots Alliance-Direktorin Ginger L. Graham wurden am 13.08.2025 als Vergütung für nicht-geschäftsführende Direktoren im Rahmen des 2021 Omnibus Incentive Plans des Unternehmens 16.820,86 Phantom-Aktieneinheiten gewährt. Jede Phantom-Einheit entspricht wirtschaftlich einer Stammaktie und wird nach Beendigung der Dienstzeit gemäß dem Plan ausgeglichen. Der gemeldete Wert pro Einheit für die Gewährung beträgt $11.89, und die Meldung zeigt nach der Transaktion einen wirtschaftlichen Besitz von 112.782,56 Phantom-Aktieneinheiten, einschließlich der statt Dividenden ausgegebenen Einheiten.

Das Formular 4 wurde im Namen von Frau Graham am 15.08.2025 von einem Bevollmächtigten, Paul Ingram, unterschrieben. Die Meldung ist eine routinemäßige Offenlegung der Vergütung von Direktoren und der aufgeschobenen aktienähnlichen Zuwendungen im Rahmen des Vergütungsrahmens für Direktoren des Emittenten.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director received a routine phantom stock award worth approximately $200k at grant value, disclosed as deferred compensation.

The grant of 16,820.86 phantom stock units at a reported per-unit value of $11.89 represents director compensation paid in arrears for prior-year services under the 2021 Omnibus Incentive Plan. Phantom units are economic equivalents of common shares and will be settled upon termination of service, creating a deferred payout obligation for the company rather than immediate share issuance. The filing discloses total phantom holdings of 112,782.56 units for the reporting person, including units issued in lieu of dividends. Impact is operationally routine and does not signal a change in company strategy or material capital structure shift.

TL;DR: This is a standard director compensation disclosure under the Omnibus Plan with deferred settlement terms and dividend-equivalent units.

The Form 4 documents an annual phantom stock grant to a non-employee director, issued in arrears and governed by the Plan’s settlement rules. The grant includes dividend-equivalent units, which were rolled into the reported balance. Such structures align director pay with shareholder economics while postponing cash or share settlement until termination. The disclosure appears complete for the transaction described and follows Section 16 reporting requirements; it is a routine governance matter without immediate material governance concerns disclosed in this filing.

La direttrice di Walgreens Boots Alliance, Ginger L. Graham, ha ricevuto 16.820,86 unità azionarie fantasma in data 13/08/2025 come compenso per direttore non dipendente ai sensi del piano 2021 Omnibus Incentive Plan dell’azienda. Ogni unità fantasma corrisponde economicamente a una azione ordinaria e verrà liquidata alla cessazione del servizio in conformità con il Piano. Il valore per unità riportato per la concessione è di $11.89, e la comunicazione indica la detenzione di 112.782,56 unità azionarie fantasma dopo l’operazione, comprensive delle unità emesse in luogo dei dividendi.

Il Modulo 4 è stato firmato per conto della Sig.ra Graham da un procuratore, Paul Ingram, in data 15/08/2025. La comunicazione è una divulgazione di routine relativa al compenso dei direttori e alle assegnazioni differite analoghe all’equity previste dal quadro retributivo per i direttori dell’emittente.

La directora de Walgreens Boots Alliance, Ginger L. Graham, recibió 16.820,86 unidades de acciones fantasma el 13/08/2025 como compensación por su cargo como directora no empleada bajo el Plan Omnibus de Incentivos 2021 de la compañía. Cada unidad fantasma equivale económicamente a una acción ordinaria y se liquidará al terminar el servicio de acuerdo con el Plan. El valor por unidad reportado para la concesión es de $11.89, y la presentación muestra 112.782,56 unidades de acciones fantasma en propiedad tras la transacción, incluyendo las unidades emitidas en lugar de dividendos.

El Formulario 4 fue firmado en nombre de la Sra. Graham por un apoderado, Paul Ingram, el 15/08/2025. La presentación es una divulgación de rutina sobre la compensación de directores y las adjudicaciones diferidas similares a acciones dentro del marco de remuneración para directores del emisor.

Walgreens Boots Alliance 이사인 Ginger L. Graham은 2025년 8월 13일 회사의 2021 Omnibus Incentive Plan에 따라 비임원 이사 보수로 16,820.86개의 팬텀 스톡 단위를 부여받았습니다. 각 팬텀 단위는 보통주 1주와 동일한 경제적 가치를 가지며, 플랜에 따라 서비스 종료 시 정산됩니다. 부여에 대한 단위당 보고 가치는 $11.89이며, 제출서류는 거래 후 배당 대신 발행된 단위를 포함하여 112,782.56개의 팬텀 스톡 단위를 실질적으로 보유하고 있음을 보여줍니다.

Form 4는 2025년 8월 15일 Ms. Graham을 대신하여 대리인 Paul Ingram이 서명했습니다. 해당 제출은 발행인의 이사 보수 체계에 따른 이사 보수 및 유사 주식형 이연 수여에 대한 일상적인 공시입니다.

La directrice de Walgreens Boots Alliance, Ginger L. Graham, s’est vu accorder 16 820,86 unités fantômes d’actions le 13/08/2025 en tant que rémunération de directrice non salariée dans le cadre du Plan d’incitation omnibus 2021 de la société. Chaque unité fantôme équivaut économiquement à une action ordinaire et sera réglée lors de la cessation de fonctions conformément au Plan. La valeur par unité déclarée pour l’attribution est de $11.89, et le dépôt indique la détention bénéficiaire de 112 782,56 unités fantômes d’actions après la transaction, incluant les unités émises en lieu et place des dividendes.

Le formulaire 4 a été signé pour Mme Graham par un mandataire, Paul Ingram, le 15/08/2025. Le dépôt constitue une divulgation de routine concernant la rémunération des administrateurs et les attributions différées assimilées à des actions dans le cadre du régime de rémunération des administrateurs de l’émetteur.

Walgreens Boots Alliance-Direktorin Ginger L. Graham wurden am 13.08.2025 als Vergütung für nicht-geschäftsführende Direktoren im Rahmen des 2021 Omnibus Incentive Plans des Unternehmens 16.820,86 Phantom-Aktieneinheiten gewährt. Jede Phantom-Einheit entspricht wirtschaftlich einer Stammaktie und wird nach Beendigung der Dienstzeit gemäß dem Plan ausgeglichen. Der gemeldete Wert pro Einheit für die Gewährung beträgt $11.89, und die Meldung zeigt nach der Transaktion einen wirtschaftlichen Besitz von 112.782,56 Phantom-Aktieneinheiten, einschließlich der statt Dividenden ausgegebenen Einheiten.

Das Formular 4 wurde im Namen von Frau Graham am 15.08.2025 von einem Bevollmächtigten, Paul Ingram, unterschrieben. Die Meldung ist eine routinemäßige Offenlegung der Vergütung von Direktoren und der aufgeschobenen aktienähnlichen Zuwendungen im Rahmen des Vergütungsrahmens für Direktoren des Emittenten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GRAHAM GINGER L

(Last) (First) (Middle)
C/O WALGREENS BOOTS ALLIANCE, INC.
108 WILMOT ROAD

(Street)
DEERFIELD IL 60015

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Walgreens Boots Alliance, Inc. [ WBA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units (1) 08/13/2025 A 16,820.86 (2) (2) Common Stock 16,820.86 $11.89 112,782.56(3) D
Explanation of Responses:
1. The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock.
2. To be settled following termination of service as a director in accordance with the terms and conditions of the Plan.
3. Includes phantom stock units that were issued in lieu of dividends on outstanding phantom stock units.
Remarks:
/s/ Ginger L. Graham by Paul Ingram, Attorney-in-Fact 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Walgreen Boots

NASDAQ:WBA

WBA Rankings

WBA Latest News

WBA Latest SEC Filings

WBA Stock Data

10.29B
713.76M
17.44%
61.48%
2.48%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States
DEERFIELD